Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma.

Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q30164581

about

Clinical relevance of neutral endopeptidase (NEP/CD10) in melanoma LAPTM4B: a novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signaling A kinase-independent role for EGF receptor in autophagy initiation Lysosomal transmembrane protein LAPTM4B promotes autophagy and tolerance to metabolic stress in cancer cells Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus Emerging roles of PtdIns(4,5)P2--beyond the plasma membrane Overexpression of LAPTM4B-35: a novel marker of poor prognosis of prostate cancer LAPTM4B is a PtdIns(4,5)P2 effector that regulates EGFR signaling, lysosomal sorting, and degradation.LAPTM4B polymorphism increases susceptibility to multiple cancers in Chinese populations: a meta-analysis.Integration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition.Highly specific targeting and imaging of live cancer cells by using a peptide probe developed from rationally designed peptides.A role for the ubiquitin ligase Nedd4 in membrane sorting of LAPTM4 proteins.LAPTM4B allele *2 is a marker of poor prognosis following hepatic tumor resection for hepatocellular carcinoma.Structure analysis and expressions of a novel tetratransmembrane protein, lysosoma-associated protein transmembrane 4 beta associated with hepatocellular carcinoma.LAPTM4B allele *2 is associated with breast cancer susceptibility and prognosis.LAPTM4B allele *2 is a marker of poor prognosis for gallbladder carcinoma Relationship Between LAPTM4B Gene Polymorphism and Susceptibility of Malignant Melanoma in Chinese Patients.cAMP responsive element binding protein-1 is a transcription factor of lysosomal-associated protein transmembrane-4 Beta in human breast cancer cells Gene-expression signatures can distinguish gastric cancer grades and stages Expressed genes in regenerating rat liver after partial hepatectomy.CIK cells from patients with HCC possess strong cytotoxicity to multidrug-resistant cell line Bel-7402/R Lysosomal-associated protein transmembrane 4 Beta-35 overexpression is a novel independent prognostic marker for gastric carcinoma.Differential expression of lysosome-associated protein transmembrane-4 beta (LAPTM4B) in granulosa cells of ovarian follicles and in other bovine tissues LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients.The relationship between LAPTM4B polymorphisms and cancer risk in Chinese Han population: a meta-analysis.Lysosomal-associated Transmembrane Protein 4B (LAPTM4B) Decreases Transforming Growth Factor β1 (TGF-β1) Production in Human Regulatory T Cells.Relationship between LAPTM4B Gene Polymorphism and Prognosis of Patients following Tumor Resection for Colorectal and Esophageal Cancers.LAPTM4B Gene Expression and Polymorphism as Diagnostic Markers of Breast Cancer in Egyptian Patients.Stress-Induced EGFR Trafficking: Mechanisms, Functions, and Therapeutic Implications.LAPTM4B-35 protein is a weak tumor-associated antigen candidate.LAPTM4B: an oncogene in various solid tumors and its functions.Targeting a novel cancer-driving protein (LAPTM4B-35) by a small molecule (ETS) to inhibit cancer growth and metastasis.Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer.Oncolytic and immunotherapeutic vaccinia induces antibody-mediated complement-dependent cancer cell lysis in humans.Increased levels of LAPTM4B, VEGF and survivin are correlated with tumor progression and poor prognosis in breast cancer patients.LAPTM4B facilitates late endosomal ceramide export to control cell death pathways.A peptide-based pH-sensitive drug delivery system for targeted ablation of cancer cells.Lentivirus-mediated RNA Interference Targeting LAPTM4B Inhibits Human Ovarian Cancer Cell Invasion In Vitro.Far-red/near-infrared fluorescence light-up probes for specific in vitro and in vivo imaging of a tumour-related protein Upregulation of LAPTM4B-35 promotes malignant transformation and tumorigenesis in L02 human liver cell line.

P2860

Q21093253-C7E8D45F-B34A-44FF-B294-A5619C401B9D Q24296238-93BC9E83-6CD7-4F55-8E51-1703C9F77710 Q24314943-3B0B2A16-B173-440A-AE8A-CA39C41A5531 Q24606012-048CDABB-FA95-4E8D-9C74-A155CF84A738 Q24681592-58512BC4-7CFA-43D6-9A04-4431C51D7E63 Q28084524-E1737D1B-CB1F-42C5-B7C7-8B180EE52FE4 Q28541215-E9E43A0E-7F0B-4792-876A-99ABEF04692B Q30360833-193D99D2-CF0A-4B2A-8FFF-EC2BDB65A23B Q33617093-EFA15479-DCDD-4B1E-98C5-41C7E72DEDB5 Q33670486-1D58E3F6-930B-4879-B993-D3C8D38D5074 Q33889674-34A0F6C9-1F3D-4BD2-81FA-7B2AEA703450 Q34077924-25937142-62A3-4D33-AE0A-DDD85595B4E8 Q34235524-A755E3F3-4C22-4402-9796-20CF72EF00B9 Q34322940-41F76F9D-EB89-4A38-BB80-12E9CC32D645 Q34416241-D8BB07D7-D40F-4F42-9189-C6DCEBB14752 Q34416440-201D3B09-CA4D-427B-8560-317F2B145687 Q34478569-FFEC2F89-D5A4-41B1-862A-22C179A817D5 Q34612174-74F531D1-B81D-41E7-B752-D414C21DC7AD Q34698991-A60D1E03-6F1A-448A-B121-EEA2BD206498 Q35010318-B0C9B5AF-0C1E-4D21-9AB9-83621D45C0DB Q35045325-2204B923-F1F8-46AE-BB93-EF3879047601 Q35092377-8FDB6957-8426-45D5-A8F8-988538B02587 Q35293320-38E096AC-1E13-458B-AB0A-D01F26B95073 Q35304103-53D99E81-FED8-4035-8B9C-86A585E6CCB0 Q35533654-8835B817-6F19-48E5-90EA-516D878DE555 Q35679014-A48B602A-39A1-4E76-9B60-E43FC0DEDEA5 Q36071233-579EBA06-3B4F-4648-AE2B-0BE1BF0DFF82 Q37041338-E4FBC994-C615-47CF-9C9E-67F4FD68C738 Q37432540-2544C4DF-ED97-4837-BA47-F2BC7AE66D27 Q37434480-7A4FEE21-FA3D-432E-8AE7-AB57960DEE1D Q37510652-645A49FC-D8F4-49D1-9546-2AEAECA3BE76 Q37629059-69EDA8C9-B893-4378-8029-04135B05810E Q37636606-FB2A2B02-46FD-437D-AA4B-51F941055770 Q38450392-BF383006-DDB8-42B7-98A6-A82663708B93 Q38801879-A65ADE9A-9A25-4CE5-94F7-67FBFB6E063D Q38843156-FB3C3887-EE22-4A8C-95AC-809979C00242 Q38843320-74C6197A-4415-409A-9F1D-FAA809DDCB1A Q38845980-5DEDDA22-D1AB-48CE-AB2B-5625E508108C Q39063834-85974760-4712-41D3-945D-C634DA17456E Q39535035-88AFB81C-347D-4212-B93B-A34FCE961A7E

P2860

Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q30164581

description

2003 nî lūn-bûn

@nan

2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Molecular cloning and characte ...... d in hepatocellular carcinoma.

@ast

Molecular cloning and characte ...... d in hepatocellular carcinoma.

@en

type

label

Molecular cloning and characte ...... d in hepatocellular carcinoma.

@ast

Molecular cloning and characte ...... d in hepatocellular carcinoma.

@en

prefLabel

Molecular cloning and characte ...... d in hepatocellular carcinoma.

@ast

Molecular cloning and characte ...... d in hepatocellular carcinoma.

@en

P1433

Q30164581-6CC2AC68-4D01-4BB9-906F-0167361F520E

P1476

Q30164581-064BAF62-BC9C-4D4B-8AE1-5FBD1DCCDD49

P2093

Q30164581-0C17C3C5-573A-4303-9172-EDEB8CF04AA1

Q30164581-604DED56-1927-4A1B-92D4-0934B3277D70

Q30164581-8B29426B-AC21-4C2B-8A17-7E1A39B5CB26

Q30164581-9C4595B9-2DF6-415E-9840-691281EE6B94

Q30164581-A4EBA1AF-0702-4F60-915E-644C6048BDFF

Q30164581-C2E3814D-B60F-4801-B6D7-B9F9CF03DD30

Q30164581-CA0BF59A-7851-4DDB-96DD-0CBACE206F91

Q30164581-E1B421F8-2F7C-4E29-A0CB-A54039A5A61A

P2860

Q30164581-7D75ABF4-8A10-4E3D-8E10-1E3A5D5473CC

Q30164581-84052BF2-B808-4E01-9ED4-35CFEAF7C184

Q30164581-888AC627-720B-4EAE-8F29-9B8A5F5FC473

Q30164581-C0AD62E3-98E6-4DF1-9170-5BBE03AA9534

P2888

Q30164581-11619C72-C630-47B7-BE17-10407A4C7324

P304

Q30164581-AA33B5FD-09D7-4E1C-BCCC-6B1B333E879B

P31

Q30164581-6DD11F35-B7F7-4F28-B0EC-662F0F7844E7

P356

Q30164581-86A3A226-8F5D-45D1-AD0A-A0BCCC4AF230

P407

Q30164581-87E4DC0C-E764-491B-BE42-8780B1A1203C

P433

Q30164581-A1113F57-AC91-4980-8C22-9203EECBF5D1

P478

Q30164581-7CCFFB02-C5E2-4BCC-A76D-C697D099CFAC

P577

Q30164581-76314E30-3EAB-47CF-9E84-6B4E50DE5E42

P5875

Q30164581-9BCE5477-A47A-4C6B-9569-5536729AFA09

P6179

Q30164581-EF96E090-ACC0-4DAA-B70D-9EB1AF983C15

P698

Q30164581-B6852B89-B56C-45C9-815C-49069EBED151

P356

P1433

P1476

Molecular cloning and characte ...... d in hepatocellular carcinoma.

@en

P2093

Da-Xiong Ye

http://www.w3.org/2001/XMLSchema#string

Gen-Ze Shao

http://www.w3.org/2001/XMLSchema#string

Jing-An Rui

http://www.w3.org/2001/XMLSchema#string

Jun-Jian Liu

http://www.w3.org/2001/XMLSchema#string

Qing-Yun Zhang

http://www.w3.org/2001/XMLSchema#string

Rou-Li Zhou

http://www.w3.org/2001/XMLSchema#string

Xue Wei

http://www.w3.org/2001/XMLSchema#string

Ye Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Studies of genetic defects in hepatocellular carcinoma: recent outcomes and new challenges.

Reduced expression and rare genomic alteration of nm23-H1 in human hepatocellular carcinoma and hepatoma cell lines.

Identification of a novel membrane transporter associated with intracellular membranes by phenotypic complementation in the yeast Saccharomyces cerevisiae.

A mammalian lysosomal membrane protein confers multidrug resistance upon expression in Saccharomyces cerevisiae.

P2888

P304

5060-5069

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.ONC.1206832

http://www.w3.org/2001/XMLSchema#string

P407

P433

32

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2003-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10626254

http://www.w3.org/2001/XMLSchema#string

P6179

1006081204

http://www.w3.org/2001/XMLSchema#string

P698

12902989

http://www.w3.org/2001/XMLSchema#string